Nest Genomics, a New York-based health technology company, raised $8.5M in Seed funding.
The round was led by B Capital, with participation from Y Combinator, Casdin Capital, DCVC, Samsung Next, Maven Ventures, iAngels, Arkin Digital Health, LionBird, Anne Wojcicki, and Deneen Vojta.
The company intends to use the funds to launch its product with additional customers, integrating with more EMRs, and expanding to other clinical specialty areas, including Pediatrics, Polygenic Risk Scores, and Pharmacogenetics.
Founded by Moran Snir (CEO) and Guy Snir, Nest Genomics is an end-to-end solution designed to help health systems, clinics, pharmaceutical companies, and payors launch and scale longitudinal genomic programs. The Electronic Medical Records (EMR)-integrated platform allows for the incorporation of genomics into clinical practice within existing workflows, including clinical decision support to help providers create patient care plans based on the latest clinical guidelines and patient information. The solution also includes patient engagement tools that empower patients to understand and manage their genetic information over time.
Nest Genomics also has offices in San Francisco and Tel Aviv.
FinSMEs
11/01/2023